Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Download PDF
April 18, 2016
/
News
Share
the Post
Related
Posts
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Asia Pacific Situational Updates on Generic DAAs – June 2017
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
Read More
Story from Ayu Oktariani, Bandung, Indonesia
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Progress report on access to hepatitis C treatment, WHO March 2018
